Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.

about

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.

Item

http://www.wikidata.org/entity/Q49558301

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.

@en

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.

@nl

type

Item

label

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.

@en

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.

@nl

prefLabel

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.

@en

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.

@nl

P1476

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer

@en

P2093

Cansu Karakas

http://www.w3.org/2001/XMLSchema#string

John A Olson

http://www.w3.org/2001/XMLSchema#string

Kelly K Hunt

http://www.w3.org/2001/XMLSchema#string

Kwang-Hui Low

http://www.w3.org/2001/XMLSchema#string

Matthew J Ellis

http://www.w3.org/2001/XMLSchema#string

Mehrnoosh Kohansal

http://www.w3.org/2001/XMLSchema#string

Stacy L Moulder

http://www.w3.org/2001/XMLSchema#string

Vera J Suman

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclin E and survival in patients with breast cancer.

Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer.

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers.

Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification

Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.

A novel interaction between HER2/neu and cyclin E in breast cancer.

LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E

P304

7288-7300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-17-1544

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Khandan Keyomarsi

Iman Doostan

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28947566

http://www.w3.org/2001/XMLSchema#string

P932

5768442

http://www.w3.org/2001/XMLSchema#string